SciELO - Scientific Electronic Library Online

 
vol.80 issue4Time to focus child survival programmes on the newborn: assessment of levels and causes of infant mortality in rural PakistanPrevalence of nutritional wasting in populations: building explanatory models using secondary data author indexsubject indexarticles search
Home Page  

Services on Demand

Journal

Article

Indicators

Related links

Share


Bulletin of the World Health Organization

Print version ISSN 0042-9686

Abstract

SCHOUB, B.D. et al. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bull World Health Organ [online]. 2002, vol.80, n.4, pp.277-281. ISSN 0042-9686.  http://dx.doi.org/10.1590/S0042-96862002000400005.

OBJETIVE: To evaluate the effectiveness of universal vaccination against viral hepatitis B in South Africa among 18-month-old rural children. METHODS: Children were immunized with a course of low-dose (1.5 mg), plasma-derived hepatitis B vaccine at 6, 10 and 14 weeks of age, and blood samples from the children were tested for three hepatitis B markers: hepatitis B surface antigen (HBsAg), anti-HBs and anti-HBc. FINDINGS: One year after vaccination, a protective anti-HBs antibody titre of at least 10 IU/l was present in 669/769 (87.0%) of blood serum samples tested. Only 3/756 children (0.4%) were HBsAg positive and a fourth child was anti-HBc positive (HBsAg negative). This is a marked decrease compared to the hepatitis B prevalences reported in previous studies. Among rural migrant mine-workers, for example, HBsAg prevalence was 9.9%, and was 10.1% among children 0-6 years of age in the Eastern Cape Province. CONCLUSION: The low-dose, plasma-derived hepatitis B vaccine, which is affordable to most developing countries, was very successful in controlling endemic hepatitis B infection, where the virus is predominantly spread by horizontal transmission among infants and young children.

Keywords : Hepatitis B vaccines [administration and dosage]; Hepatitis B vaccines [economics]; Hepatitis B surface antigens [blood]; Child; Endemic diseases [immunology]; Immunization programs; Evaluation studies; Cross-sectional studies; South Africa.

        · abstract in French | Spanish     · text in English     · English ( pdf )